Top

World Journal of Surgery

Published in:

01-06-2015 | Original Scientific Report

Macrometastasis, Micrometastasis, and Isolated Tumor Cells in Sentinel Lymph Nodes of Early Breast Cancers: A 10-Year Histopathological and Survival Analysis of 537 Asian Patients

Authors: Michael Co, Ava Kwong

Published in: World Journal of Surgery | Issue 6/2015

Abstract

Background

In patients with negative sentinel lymph node biopsy (SLNB), axillary dissection (AD) can be avoided to reduce morbidities. However, there is only limited data on the rate of positive non-SLN (NSLN) in those who have micrometastasis and isolated tumor cells (ITC) in the literature.

Methods

We did a retrospective review of all clinically node-negative breast cancer patients with SLNB done at our unit from January 2001 to June 2011. Multivariate analysis was adopted to evaluate the risk factors for NSLN metastasis. Difference in 5-year disease-free survival (DFS) was evaluated with log-rank test.

Results

Five-hundred and thirty-seven patients underwent SLNB; 161 (30 %) had positive SLN on frozen section (FS), 50 of these patients (31 %) had NSLN metastasis, 25 patients had negative SLN on FS but were found to have micrometastasis on histopathology, and only 1 (4 %) of them had NSLN metastasis, while 14 patients were found to have ITC in SLN; none of them had NSLN metastasis. Multivariate analysis found that the number of SLN harboring micrometastasis is the only independent risk factor for NSLN metastasis in patients with micrometastasis (p value = 0.008). On the contrary; tumor size, grade, and biology were not associated with NSLN metastasis. 5-year DFS in patients with macrometastasis in SLN was 94.2 %, while that in patients with micrometastasis and ITC was 100 % (p value <0.001).

Conclusion

NSLN metastasis in those who only have micrometastasis and ITC is rare, and 5-year DFS is significantly better in this group of patients as well. It is therefore a routine practice in our unit to omit AD in patients with micrometastasis and ITC on SLN.

Kim T, Guiliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 106:4–16CrossRefPubMed

Veronesi U, Viale G, Paganelli G et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251:595–600CrossRefPubMed

Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B32 randomised phase III trial. Lancet Oncol 8:881–888CrossRefPubMed

Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599–609CrossRefPubMed

Zavagno G, De Salvo GL, Scalco G et al (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247:207–213CrossRefPubMed

Gill G (2009) Sentinel lymph-node based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16:266–275CrossRefPubMed

Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel lymph node resection compared with conventional axillary lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933CrossRefPubMedCentralPubMed

Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452–461CrossRefPubMedCentralPubMed

Mathew J, Barthelmes L, Neminathan S, Crawford D (2006) Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery. Eur J Surg Oncol 32:729–732CrossRefPubMed

10.

Silberman AW, McVay C, Cohen JS et al (2004) Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg 240:1–6CrossRefPubMedCentralPubMed

11.

Golshan M, Martin WJ, Dowlatshahi K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209–211PubMed

12.

Meric F, Buchholz TA, Mirza NQ et al (2002) Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9:543–549CrossRefPubMed

13.

Dowlatshahi K, Fan M, Bloom KJ et al (1999) Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 86:990–996CrossRefPubMed

14.

Dowlatshahi K, Fan M, Snider HC et al (1997) Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. doi:10.1002/(SICI)1097-0142(19971001)80:7 PubMed

15.

Noguchi M (2008) Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. J Clin Oncol 26:2093–2098CrossRef

16.

Cox Charles E, Kiluk John V, Riker Adam I et al (2008) Significance of sentinel lymph node micrometastasis in human breast cancer. J Am Coll Surg 206(2):261–268CrossRefPubMed

17.

de Boer M, van Deurzen CH, van Dijck JA et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361(7):653–663CrossRefPubMed

18.

Bilimoria KY, Bentrem DJ, Hansen NM et al (2009) Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27:2946–2953CrossRefPubMed

19.

Giuliano AE, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426–433PubMed

Title: Macrometastasis, Micrometastasis, and Isolated Tumor Cells in Sentinel Lymph Nodes of Early Breast Cancers: A 10-Year Histopathological and Survival Analysis of 537 Asian Patients
Authors: Michael Co
Ava Kwong
Publication date: 01-06-2015
Publisher: Springer International Publishing
Published in: World Journal of Surgery / Issue 6/2015
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-015-2984-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Macrometastasis, Micrometastasis, and Isolated Tumor Cells in Sentinel Lymph Nodes of Early Breast Cancers: A 10-Year Histopathological and Survival Analysis of 537 Asian Patients

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2015

Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: Surgical Outcomes and the Prognostic Impact of Concomitant Major Vascular Invasion

Deficiencies in the Availability of Essential Musculoskeletal Surgical Services at 883 Health Facilities in 24 Low- and Lower-Middle-Income Countries

Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis

Importance of Factors Affecting Serum Leptin Levels

The SF-36 and 6-Minute Walk Test are Significant Predictors of Complications After Major Surgery

Penetrating Extremity Trauma